Mavrilimumab Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Mavrilimumab (CAM-3001) is an investigational human IgG4 monoclonal antibody (MAb) targeting GM-CSF receptor alpha which is currently being developed for the treatment of RA. GM-CSF plays a central role in the pathogenesis of rheumatoid arthritis (RA) through the activation, differentiation, and survival of macrophages and neutrophils.
Mavrilimumab Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte